Haemonetics Stock Hits 52-Week High on Expanded CSL Plasma Deal

Key Facts

1Haemonetics stock reached a new 52-week high following CSL Plasma's announcement of a sweeping technology rollout across its U.S. centers.

Haemonetics stock reached a new 52-week high following CSL Plasma's announcement of a sweeping technology rollout across its U.S. centers. Benzinga reported that the rally followed a commitment to deploy Haemonetics' technology across existing plasma collection facilities.

HAE closed at $101.71 on October 7, 2026, after trading between a day low of $101.32 and a day high of $104.02. The expansion of the supply and technology partnership signals increased revenue certainty for the company within the plasma collection sector.